Northern Trust Corp Grows Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Northern Trust Corp lifted its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 10.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 813,076 shares of the company's stock after purchasing an additional 80,055 shares during the period. Northern Trust Corp owned 1.64% of Prestige Consumer Healthcare worth $63,493,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Franklin Resources Inc. boosted its stake in Prestige Consumer Healthcare by 0.7% during the fourth quarter. Franklin Resources Inc. now owns 21,735 shares of the company's stock worth $1,697,000 after buying an additional 150 shares during the last quarter. CIBC Private Wealth Group LLC boosted its position in shares of Prestige Consumer Healthcare by 48.9% during the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after acquiring an additional 152 shares during the last quarter. QRG Capital Management Inc. grew its holdings in shares of Prestige Consumer Healthcare by 3.3% in the fourth quarter. QRG Capital Management Inc. now owns 5,496 shares of the company's stock valued at $429,000 after purchasing an additional 176 shares during the period. O Shaughnessy Asset Management LLC increased its position in Prestige Consumer Healthcare by 3.0% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 7,026 shares of the company's stock worth $549,000 after purchasing an additional 207 shares during the last quarter. Finally, Summit Investment Advisors Inc. raised its stake in Prestige Consumer Healthcare by 4.2% during the fourth quarter. Summit Investment Advisors Inc. now owns 5,182 shares of the company's stock worth $405,000 after purchasing an additional 211 shares during the period. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Price Performance

PBH stock opened at $80.99 on Wednesday. The business's fifty day moving average price is $83.15 and its 200 day moving average price is $81.11. Prestige Consumer Healthcare Inc. has a 12-month low of $62.35 and a 12-month high of $90.04. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. The company has a market capitalization of $4.01 billion, a PE ratio of 18.97, a P/E/G ratio of 2.69 and a beta of 0.44.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Insider Activity

In related news, SVP Mary Beth Fritz sold 1,678 shares of the company's stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the sale, the senior vice president now directly owns 17,157 shares in the company, valued at approximately $1,544,130. This represents a 8.91 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.60% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Canaccord Genuity Group raised their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a report on Friday, February 7th. DA Davidson lifted their target price on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a research report on Friday, February 7th. StockNews.com upgraded Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Tuesday, April 29th. Oppenheimer raised their price objective on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a research report on Thursday, February 13th. Finally, Royal Bank of Canada upped their target price on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a "sector perform" rating in a research report on Friday, March 21st. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.